Chevalley T - Search Results

1

[Multiple myeloma in the elderly : impact of a geriatric assessment].

Bruno B, De Ramon Ortiz C, Ligozat S, Samii K, Chevalley T. Bruno B, et al. Among authors: chevalley t. Rev Med Suisse. 2019 Nov 6;15(670):2032-2038. Rev Med Suisse. 2019. PMID: 31696678 Review. French.

2

Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group.

Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, Cooper C, Al-Daghri N, Bock O, Bruyère O, Rosa MM, Cortet B, Cruz-Jentoft AJ, Cherubini A, Dawson-Hughes B, Fielding R, Fuggle N, Halbout P, Kanis JA, Kaufman JM, Lamy O, Laslop A, Yerro MCP, Radermecker R, Thiyagarajan JA, Thomas T, Veronese N, de Wit M, Reginster JY, Rizzoli R. Chevalley T, et al. Aging Clin Exp Res. 2022 Nov;34(11):2603-2623. doi: 10.1007/s40520-022-02279-6. Epub 2022 Oct 26. Aging Clin Exp Res. 2022. PMID: 36287325 Free PMC article. Review.

3

Dexamethasone enhances the osteogenic effects of fluoride in human TE85 osteosarcoma cells in vitro.

Takada J, Chevalley T, Baylink DJ, Lau KH. Takada J, et al. Among authors: chevalley t. Calcif Tissue Int. 1996 May;58(5):355-61. doi: 10.1007/BF02509385. Calcif Tissue Int. 1996. PMID: 8661971

4

Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation.

Chevalley T, Strong DD, Mohan S, Baylink D, Linkhart TA. Chevalley T, et al. Eur J Endocrinol. 1996 May;134(5):591-601. doi: 10.1530/eje.0.1340591. Eur J Endocrinol. 1996. PMID: 8664980

5

Effect of tumor necrosis factor-alpha on the expression of insulin-like growth factor I and insulin-like growth factor binding protein 4 in mouse osteoblasts.

Scharla SH, Strong DD, Mohan S, Chevalley T, Linkhart TA. Scharla SH, et al. Among authors: chevalley t. Eur J Endocrinol. 1994 Sep;131(3):293-301. doi: 10.1530/eje.0.1310293. Eur J Endocrinol. 1994. PMID: 7522842

6

[Incidence of hip fracture: reversal of a secular trend].

Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin CH, Rizzoli R. Chevalley T, et al. Rev Med Suisse. 2007 Jun 13;3(115):1528-30, 1532-3. Rev Med Suisse. 2007. PMID: 17682797 French.

7

[General trend of hip fractures].

Chevalley T, Herrmann FR, Guilley E, Hoffmeyer P, Rizzoli R. Chevalley T, et al. Rev Med Suisse. 2011 Jun 15;7(299):1294-8. Rev Med Suisse. 2011. PMID: 21793418 French.

8

[Orthogeriatric care : what specificities ?].

Chevalley T, Ammann P. Chevalley T, et al. Rev Med Suisse. 2019 Apr 17;15(647):810-814. Rev Med Suisse. 2019. PMID: 30994982 French.

9

[Development and evaluation of Fracture Liaison Service in Switzerland].

Chevalley T, Cruz-Tochon A, Portela M, Padlina I, Brulhart-Citozi D, Ferrari S. Chevalley T, et al. Rev Med Suisse. 2021 Apr 21;17(735):780-783. Rev Med Suisse. 2021. PMID: 33881240 French.

10

[Metabolic bone diseases : what's new in 2023].

Ferrari S, Trombetti A, Debrach AC, Kozycki S, Padlina I, Chevalley T, Biver E. Ferrari S, et al. Among authors: chevalley t. Rev Med Suisse. 2024 Jan 31;20(859):255-258. doi: 10.53738/REVMED.2024.20.859.255. Rev Med Suisse. 2024. PMID: 38299957 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

100 results

Search Page